Sequential is a biotechnology company that offers an AI-powered, multi-omics clinical research platform for the personal care and pharmaceutical industries to validate product efficacy and discover new bioactive ingredients.
Company size
Less than 500 employees
Portfolio summary
In vivo skin microbiome testing, multi-omic clinical studies, the non-invasive Sequential Patch skin-sampling device, formulation co-development, and targeted microbiome panel analysis for the skincare, haircare, oral, and intimate care industries
Markets served
APAC · EMEA · NA
R&D locations
London, United Kingdom · Singapore · New York City, New York · Cambridge, United Kingdom
Sequential is a biotech company specializing in genomic testing and AI-driven discovery platforms for skin health and microbiome research.